Advertisement
Screener

CalciMedica, Inc. (CALC) EBITDA

CalciMedica, Inc. (CALC) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income -$4.01M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$5.61M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA (m); Operating income -$5.62M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income -$6.62M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2022-03-31 to 2023-12-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$4.01M(m)(m)(m)$0.00*-$4.62M*(m)$2.10M(m)$0.00
2026-03-31Reported(m)-$5.61M(m)(m)(m)$0.00-$4.86M(m)$3.48M(m)$0.00
2025-09-30Reported(m)-$5.62M(m)(m)(m)$8.00K*-$4.78M*(m)$3.85M(m)$0.00
2025-06-30Reported(m)-$6.62M(m)(m)(m)$5.00K*-$6.67M*(m)$4.05M(m)$0.00
2025-03-31Reported(m)-$6.50M(m)(m)(m)$9.00K-$4.88M(m)$4.22M(m)$0.00
2024-09-30Reported(m)-$5.74M(m)(m)(m)$6.00K*-$4.67M*(m)$3.55M(m)$0.00
2024-06-30Reported(m)-$6.53M(m)(m)(m)$0.00*-$6.79M*(m)$4.16M(m)$0.00
2024-03-31Reported(m)-$5.77M(m)(m)(m)$0.00-$4.71M(m)$2.94M(m)$0.00
2023-12-31Reported-$4.3M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$4.82M*-$4.83M$12.00K*(m)(m)$0.00*-$4.57M*(m)$2.77M(m)$0.00
2023-06-30Reported-$6.57M*-$6.58M$14.00K*(m)(m)(m)-$12.19M*(m)$3.81M(m)$0.00
2023-03-31Reported-$22.33M(m)(m)(m)(m)(m)-$5.36M(m)$6.49M(m)$0.00
2022-12-31Reported-$3.09M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$3.27M*-$3.29M$13.00K*(m)(m)$0.00*-$1.83M*(m)$1.24M(m)$0.00
2022-06-30Reported-$3.58M*-$3.59M$13.00K*(m)(m)$0.00*-$2.22M*(m)$2.26M(m)$0.00
2022-03-31Reported-$4.2M(m)(m)(m)(m)$4.00K-$3.63M(m)$2.92M(m)$0.00
2021-09-30Reported(m)-$8.02M(m)(m)(m)$180.00K*-$5.50M*(m)$4.02M(m)$0.00
2021-06-30Reported(m)-$7.74M(m)(m)(m)$168.00K*-$7.78M*(m)$4.17M(m)$0.00
2021-03-31Reported(m)-$11.49M(m)(m)(m)$136.00K-$9.26M(m)$6.45M(m)$0.00
2020-09-30Reported(m)-$6.82M(m)(m)(m)$43.00K*-$5.36M*(m)$4.76M(m)$0.00
2020-06-30Reported(m)-$6.04M(m)(m)(m)$7.00K*-$6.22M*(m)$4.63M(m)$0.00
2020-03-31Reported(m)-$7.80M(m)(m)(m)$147.00K-$10.71M(m)$6.08M(m)$0.00
2019-09-30Reported(m)-$10.37M(m)(m)(m)(m)(m)(m)$8.40M(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$23.12M(m)(m)(m)$28.00K-$21.18M(m)$15.23M(m)$0.00
2024-12-31Reported(m)-$24.20M(m)(m)(m)$8.00K-$21.15M(m)$14.48M(m)$0.00
2023-12-31Reported-$38.02M(m)(m)(m)(m)$78.00K-$25.73M(m)$15.86M(m)$1.00K
2022-12-31Reported-$14.14M(m)(m)(m)(m)$4.00K-$11.76M(m)$8.35M(m)$1.00K
2021-12-31Reported(m)-$35.95M(m)(m)(m)$488.00K-$31.50M(m)$18.90M(m)(m)
2020-12-31Reported(m)-$29.83M(m)(m)(m)$1.02M-$32.06M(m)$20.96M(m)(m)
2019-12-31Reported(m)-$37.50M(m)(m)(m)$605.00K-$31.21M(m)$30.58M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
TALPHERA, INC. (TLPH)United States$0.060B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99